tiprankstipranks
Advertisement
Advertisement

Tristel to Outline Strategy at ShareSoc Growth Event in Leeds

Story Highlights
  • Tristel develops chlorine dioxide-based infection prevention products for hospitals worldwide.
  • Tristel’s CFO will present the company and strategy at a ShareSoc investor event in Leeds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tristel to Outline Strategy at ShareSoc Growth Event in Leeds

Meet Samuel – Your Personal Investing Prophet

An announcement from Tristel ( (GB:TSTL) ) is now available.

Tristel plc, the AIM-listed infection prevention company headquartered near Cambridge, develops and manufactures chlorine dioxide-based disinfection products for medical devices and hospital surfaces, employing around 250 staff across 14 subsidiaries and serving 40 international markets. Its portfolio, marketed under the Tristel and Cache brands, positions the group as a specialist supplier to healthcare providers seeking effective and more sustainable decontamination solutions.

The company will present at the ShareSoc Growth Company investor event in Leeds on 14 April 2026, where CFO Anna Wasyl will outline Tristel’s business and strategy to private and growth-focused investors. While management has confirmed that no new information will be disclosed, the appearance underscores Tristel’s ongoing investor relations efforts and may help broaden its shareholder base and visibility in the UK small-cap market.

The most recent analyst rating on (GB:TSTL) stock is a Hold with a £421.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.

Spark’s Take on TSTL Stock

According to Spark, TipRanks’ AI Analyst, TSTL is a Outperform.

The score is driven primarily by strong financial performance and a constructive earnings update with reiterated growth/margin targets and solid H1 results. Offsetting factors are weak near-term technical momentum (below key moving averages with negative MACD) and a relatively high P/E, partially balanced by the ~3.6% dividend yield.

To see Spark’s full report on TSTL stock, click here.

More about Tristel

Tristel plc is a global infection prevention specialist focused on manufacturing and supplying products based on its proprietary chlorine dioxide chemistry. The company is a market leader in manual decontamination of medical devices under the Tristel brand and offers Cache-branded sporicidal surface disinfectants as a sustainable alternative to pre-wetted plastic wipes, selling from its UK base into 40 countries.

Average Trading Volume: 119,510

Technical Sentiment Signal: Buy

Current Market Cap: £188.1M

See more insights into TSTL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1